Future outlook: what comes next for both compounds The peptide weight loss landscape is evolving rapidly, and both cagrilintide and retatrutide sit at the center of that evolution
With current systems in place to meet the evolving demands of each phase from discovery through regulatory-compliant manufacturing MS-based solutions deliver the data integrity, scalability and regulatory compliance that developers need to bring safe, effective peptide therapeutics to market faster
[5] The most scientifically cautious interpretation is not that broad off-target inhibition has been proven, but that broader non-target effects cannot be excluded when experiments use high concentrations, long exposure windows, sensitive cell systems, or designs lacking orthogonal NNMT validation
However, this increase in melanin is not always desired, especially when it leads to conditions like dark spots, melasma, or other forms of skin discoloration